N/A
N=494
Comparative Effectiveness Study of Transthoracic and Transesophageal Echocardiography in Stroke
Stroke, Acute
Bottom Line
View on ClinicalTrials.gov: NCT03411642 ↗Enrolled (actual)
494
Serious AEs
0.0%
Results posted
Sep 2023
Primary outcome: Primary: Number of Participants With Diagnostic Findings That Lead to a Change in Acute Treatment or Treatment for Secondary Prevention — 64; 390; 86; 368 Participants
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- —
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Universitätsklinikum Hamburg-Eppendorf
- Primary completion
- Jun 2019
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Participants With Diagnostic Findings That Lead to a Change in Acute Treatment or Treatment for Secondary Prevention |
64; 390; 86; 368 | — |
| SECONDARY Number of Patients With Change of Assessment of Stroke Etiology After TEE |
52; 401; 1 | — |
Summary
The Comparative Effectiveness Study of Transthoracic and Transesophageal Echocardiography in Stroke (CONTEST) aims at assessing the diagnostic value of transesophageal echocardiography (TEE) and transthoracic echocardiography (TTE) with regards to treatment consequences in patients with acute ischemic stroke.
Eligibility Criteria
Inclusion Criteria
- acute ischemic stroke or transitory ischemic attack (TIA)
- age ≥18 years
- informed consent
Exclusion Criteria
- Patients with already defined stroke etiology and determined secondary prevention treatment strategy prior to echocardiography (e.g. atrial fibrillation, carotid artery stenosis, cervical artery dissection)
Data sourced from ClinicalTrials.gov (NCT03411642). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.